Cipla is seeking fast-track approvals to bring Moderna’s single-dose Covid-19 booster to India. Cipla has asked the Centre for certain indemnifications and exemptions to expedite the process. The pharma company has said that it is close to committing more than $1 billion as an advance to Moderna. Cipla has requested confirmation from the government of 4 critical points.
Jun 01, 2021, 10:21AM ISTSource: Times Now